SK bioscience to Develop AI Vaccine Platform Funded by Bill & Melinda Gates Foundation
SK bioscience will lead the ROTOR project, a new initiative funded by the Bill & Melinda Gates Foundation that utilizes artificial intelligence to minimize uncertainty during the vaccine development process. The project aims to create a digital platform designed to assist researchers and developers in making more informed, data-driven decisions throughout the various stages of vaccine creation.
The platform functions by integrating AI technology to analyze complex variables that typically complicate the development cycle. By providing a more structured framework for evaluating potential outcomes, the project seeks to streamline the decision-making process for new vaccines. The Bill & Melinda Gates Foundation provides the financial backing for this initiative, while SK bioscience oversees the technical implementation and management of the platform’s development.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: July 3, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]





